Phase I Trial of Docetaxel With Estramustine in Androgen-Independent Prostate Cancer
- 1 March 1999
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 17 (3), 958
- https://doi.org/10.1200/jco.1999.17.3.958
Abstract
PURPOSE: To evaluate the toxicity, efficacy, and pharmacokinetics of docetaxel when combined with oral estramustine and dexamethasone in a phase I study in patients with progressive metastatic andr...Keywords
This publication has 26 references indexed in Scilit:
- Estramustine and vinblastine for patients with progressive androgen-independent adenocarcinoma of the prostateUrologic Oncology: Seminars and Original Investigations, 1995
- Estramustine Phosphate SodiumDrugs & Aging, 1995
- Modulation of the Function of p-glycoprotein by EstramustineJNCI Journal of the National Cancer Institute, 1994
- P-glycoprotein Binding and Modulation of the Multidrug-Resistant Phenotype by EstramustineJNCI Journal of the National Cancer Institute, 1994
- Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: Reversibility, ligand stoichiometry, and competitionBiochemistry, 1993
- Determination of Taxotere in human plasma by a semi-automated high-performance liquid chromatographic methodJournal of Chromatography B: Biomedical Sciences and Applications, 1992
- Estramustine binds a MAP-1-like protein to inhibit microtubule assembly in vitro and disrupt microtubule organization in DU 145 cells.The Journal of cell biology, 1988
- Clinical pharmacokinetics of estramustine phosphateUrology, 1984
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958